SERPINE1 and cancer: In addition to the above, tumor cells (as well as platelets and ECs) may also release the plasminogen activator inhibitor type I (PAI-1), which inhibits fibrinolysis and promotes coagulation, actions that may increase the risk of thrombosis in cancer [129] as well as stimulating tumor growth, cancer cell survival and metastasis [130].